Overview

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

Status:
Completed

Trial end date:
2017-03-01

Target enrollment:

Participant gender:

Summary

A randomized controlled single-blind clinical trial was performed, in 32 patients diagnosed with peritoneal carcinomatosis from epithelial ovarian cancer, who underwent radical surgery-peritonectomy, achieving an optimal R0-R1 cytoreduction (microscopic tumor residues (R0) or macroscopic tumor residues < 1cm (R1)) followed by hyperthermia against normothermia intraperitoneal intraoperative chemotherapy with paclitaxel

Phase:

Phase 2

Details

Lead Sponsor:

Maimónides Biomedical Research Institute of Córdoba

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel